Project Grant F31DA062425

Award Date 6/16/25
Completion Date 8/31/26
Dollars Obligated $78K
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
New Mexico, USA
Similar Awards
This $385,000 federal Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support a comprehensive analysis of treatment patterns, outcomes, and predictive factors for patients with co-occurring opioid use disorder (OUD) and alcohol use disorder (AUD). The research aims to assess the effectiveness of integrated treatment approaches, including first-line OUD and AUD medications as well as glucagon-like peptide-1...
This federal Project Grant award of $351,413 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) grant program, supports a longitudinal study examining changes in social cognition and emotion processing among individuals with Alcohol Use Disorder (AUD) during early abstinence. The study will recruit recently abstinent AUD patients in residential treatment, as well as matched community controls, to assess trajectories of...
This federal Project Grant award of $630,000 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to develop and refine a brief, digitally-enhanced intervention called IMPROVE to reduce alcohol use among individuals engaged in medication for opioid use disorder (MOUD) treatment. The project will leverage the infrastructure of The Ohio State University's addiction treatment center and a community partner to adapt the IMPROVE...
This Project Grant award from the National Institute on Drug Abuse (NIDA), part of the Drug Use and Addiction Research Programs (CFDA 93.279), will provide $106,714 to The University of Kentucky Research Foundation from June 1, 2024 to May 31, 2026. The project aims to advance scientific understanding of the criminal legal system's influence on opioid use disorder (OUD) treatment and recovery using a socioecological approach. The mixed-methods study will: 1) examine the impact of the criminal...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to address racial disparities in opioid overdose deaths. The $451,962 grant, awarded on July 1, 2024, supports the development and evaluation of a multimodal intervention consisting of an AI-driven texting tool and peer recovery coach (PRC) telephone-based services coordination for Black and Latinx people who use opioids. The key products and services to...
The federal Cooperative Agreement award, totaling $1,837,542 and awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a project to investigate the safety, preliminary efficacy, and psycho-physiological mechanisms of combining Mindfulness-Oriented Recovery Enhancement (MORE) therapy with ketamine for the treatment of treatment-resistant opioid use disorder (OUD) in patients receiving buprenorphine. The project will...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273), provides $630,362.00 to Carnegie Mellon University to conduct research on how close relationships and alcohol use disorder (AUD) risk are connected. The project aims to develop a novel conceptual model that explores how poor relationship quality can impact how couples experience and respond to alcohol, which may then lead to heavier drinking and...
The National Institute on Drug Abuse (NIDA) awarded a $390,000 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Regents of the University of Michigan. The grant, titled "Cultivating Recovery: A Pilot Study of Digital Contingency Management for Co-Occurring Opioid and Alcohol Use Disorder," will fund a mixed-methods randomized pilot trial to test the feasibility and acceptability of a digital contingency management intervention for Medicaid...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $639,409.00 to the University of Illinois to conduct a longitudinal study examining the social and environmental influences on substance use, mental health, and suicidality among non-prescriber/non-executive healthcare workers in the United States. The key objectives are to: 1) evaluate the effects of moral injury on changes in substance...
This federal Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), is for $210,600 over a 5-year period from July 1, 2024 to June 30, 2029. The award will support Dr. Michael Incze, a general internist and addiction medicine physician, to design, refine, and pilot test an interdisciplinary "Addiction Care Transition (INTACT) Team" intervention. This intervention aims to improve transitions to primary...

BEING "IN SYNC" WITH OTHERS DURING EARLY ALCOHOL AND OPIOID RECOVERY: THE ROLE OF POSITIVE SOCIAL INTERACTIONS IN GENERATING RECOVERY CAPITAL AND BUFFERING HEALTH DISPARITIES - PROJECT SUMMARY/ABSTRACT BOTH POSITIVE EMOTIONAL FUNCTIONING AND SOCIAL CONNECTION ARE IMPORTANT TO SUBSTANCE USE DISORDER RECOVERY, BUT SCARCE RESEARCH HAS INVESTIGATED HOW THEY ARE INTERTWINED. "POSITIVITY RESONANCE" IS WHAT HAPPENS WHEN TWO OR MORE PEOPLE SHARE POSITIVE EMOTIONS, MUTUAL CARE FOR EACH OTHER, AND BIOBEHAVIORAL SYNCHRONY (E.G., EYE CONTACT). THIS CONSTRUCT HAS GAINED TRACTION IN POSITIVE AFFECTIVE RESEARCH AS AN INDICATOR OF POSITIVE EMOTIONAL FUNCTIONING AND HIGH-QUALITY SOCIAL INTERACTION BETWEEN PERSONS, THEREBY FUNCTIONING TO HAVE A LASTING UPWARD SPIRAL EFFECT ON HEALTH AND WELL-BEING IN BOTH INDIVIDUALS AND COMMUNITIES ACROSS A RANGE OF CONTEXTS. STUDYING HOW POSITIVITY RESONANCE MIGHT BE RELATED TO RECOVERY OUTCOMES FOR PEOPLE IN EARLY RECOVERY COULD HELP SHED LIGHT ON THE ROLE OF THIS SUPPORTIVE FACTOR IN THE RECOVERY PROCESS. GIVEN THE ESTABLISHED LINK BETWEEN CERTAIN DISADVANTAGED SOCIAL DETERMINANTS OF HEALTH (SDOH) AND LESS-FAVORABLE SOCIAL CONNECTEDNESS AND POSITIVE EMOTIONAL FUNCTIONING, EXPERIENCING POSITIVITY RESONANCE IN RECOVERY MAY BUFFER AGAINST THE DELETERIOUS EFFECTS OF CERTAIN SDOH. THIS STUDY PROPOSES TO EXAMINE AN UNDERSTUDIED INTERPERSONAL AFFECTIVE CONSTRUCT, POSITIVITY RESONANCE, ACROSS A DIVERSE SAMPLE OF PEOPLE WITH VARIED RECOVERY PATHWAYS. FIRST (AIM 1), WE WILL CONDUCT SECONDARY DATA ANALYSIS OF TWO STUDIES: (1) A RANDOMIZED CONTROLLED TRIAL OF ZOOM-DELIVERED MINDFULNESS-BASED RELAPSE PREVENTION COMPARED TO REFERRAL TO ONLINE MUTUAL HELP AS AFTERCARE AMONG N=430 PEOPLE IN ALCOHOL USE DISORDER (AUD) RECOVERY NATIONWIDE ("THRIVE STUDY"); AND (2) A LONGITUDINAL NATURALISTIC STUDY OF N=64 PEOPLE RECEIVING MEDICATION FOR OPIOID USE DISORDER (MOUD) CLINICAL CARE NEAR RECOVERY COMMUNITY CENTERS (RCCS) IN PREDOMINANTLY BLACK AMERICAN COMMUNITIES ("RCC MOUD STUDY"). WE WILL USE LATENT GROWTH CURVE AND PARALLEL PROCESS MODELS TO EXAMINE HOW POSITIVITY RESONANCE CHANGES ALONGSIDE RECOVERY CAPITAL (MEASURED VIA THE BRIEF ASSESSMENT OF RECOVERY CAPITAL) OVER 1 YEAR. AIM 2 WILL EXAMINE THE MODERATING ROLE OF POSITIVITY RESONANCE IN THE RELATIONSHIP BETWEEN CERTAIN SDOH (E.G., INCOME, EDUCATION, HOUSING) AND RECOVERY CAPITAL ACROSS BOTH STUDIES, USING A SERIES OF MODERATION ANALYSES. LASTLY, AIM 3 WILL INVOLVE CONDUCTING INDIVIDUAL INTERVIEWS, AND SUBSEQUENT QUALITATIVE ANALYSIS USING A GROUNDED THEORY APPROACH, WITH A SUBSAMPLE OF INTERESTED PARTICIPANTS FROM EACH PARENT STUDY (N=15 FROM EACH STUDY) IN ORDER TO CONTEXTUALIZE QUANTITATIVE FINDINGS AND MORE HOLISTICALLY EXPLORE HOW POSITIVITY RESONANCE OCCURS IN RECOVERY AND ITS EFFECTS. THE RESULTS OF THIS STUDY WILL INCREASE UNDERSTANDING OF HOW POSITIVITY RESONANCE, A CONSTRUCT CAPTURING INTERPERSONAL POSITIVE EMOTIONAL FUNCTIONING WITH LINKS TO ADAPTIVE INDIVIDUAL- AND COMMUNITY-LEVEL HEALTH OUTCOMES, CAN FACILITATE SUBSTANCE USE DISORDER RECOVERY. RESULTS MIGHT IDENTIFY A TREATMENT TARGET AND/OR EXPLICATE MECHANISMS OF PEER RECOVERY SUPPORT, AND HOW APPLICABLE POSITIVITY RESONANCE IS TO THOSE WITH MORE DISADVANTAGED SDOH.

Posted 12/16/24, 12:00 AM